Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Phase I study of Avant's vaccine delivery system shows promising results

Aug. 24, 1999

Dynavax completes patient enrollment and dosing in phase I ragweed allergy trial

Aug. 24, 1999

Xoma and Genentech expand hu1124 collaboration to include transplantation

Aug. 23, 1999

Known anti-HIV compound also shows potential in treating immune disorders

Aug. 20, 1999

SangStat's cold storage solution for donor hearts cleared by FDA

Aug. 19, 1999

New transplant agent marketed by Roche in U.K.

Aug. 18, 1999

Isotechnika advances development of new immunosuppressant

Aug. 17, 1999

Cangene receives notification of fast-track status for new anti-chickenpox product

Aug. 16, 1999

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Aug. 16, 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...